← back to search

Xuelian Wei

Verve Therapeutics (United States) · US
Area of research
Infectious Diseases · Nephrology
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Renal Diseases and Glomerulopathies, and HIV-related health complications and treatments.
h-index
22
citations
4,482
works
46
NIH funding
primary concept
Medicine
email

Recent publications

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
New England Journal of Medicine 2025cited by 22position: middledoi
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
Kidney International 2024cited by 108position: middledoi
Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
Journal of the American Society of Nephrology 2024cited by 48position: middledoi
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
New England Journal of Medicine 2020cited by 1,436position: middledoi
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
Clinical Infectious Diseases 2019cited by 737position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2024–2025)Vivekanand Jha · Rajamangala Institute of kidney disease3 papers (2024–2025)Jonathan Barratt · University of Leicester3 papers (2024–2025)Richard Phoon · The University of Sydney3 papers (2024–2025)Richard Lafayette · Palo Alto University3 papers (2024–2025)Vladimı́r Tesař · University Hospital Cologne3 papers (2024–2025)Bart Maes · AZ Delta3 papers (2024–2025)Harmeet Singh · University of Manitoba2 papers (2024–2024)Jürgen Floege · University of Hong Kong2 papers (2024–2024)Robert Brenner · Indiana University School of Medicine2 papers (2024–2025) · 2 papers (2024–2024)Sean J. Barbour · Provincial Health Services Authority2 papers (2024–2025) · 1 papers (2019–2019) · 1 papers (2025–2025)Grace A. McComsey · University Hospitals of Cleveland1 papers (2019–2019)Paul E. Sax · Harvard University1 papers (2019–2019)Dana V. Rizk · University of Alabama at Birmingham1 papers (2025–2025)Rubeen Israni · Novartis (Switzerland)1 papers (2024–2024)Kristine M. Erlandson · Colorado Northwestern Community College1 papers (2019–2019)Chloe Orkin · Royal London Hospital1 papers (2019–2019)